Pharmaceutical Technology on MSN
Immunai and Boehringer partner to identify T-cell targets
The collaboration will see the companies gather and analyse data from many patient samples.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS). Current therapies for relapsing MS primarily target the peripheral immune system but have consistently ...
Mitochondria are the energy production centers in cells and have unique genetic information. Due to the irreplaceable function of mitochondria, mitochondrial dysfunction often leads to pathological ...
RNA-based hTERT therapy may enhance telomere activity, improving lung cell health in pulmonary fibrosis (PF). Telomere dysfunction is a significant risk factor for PF, with telomerase reactivation ...
Chen et al. construct a comprehensive immune landscape of lymphatic malformations (LMs) atlas at single-cell resolution, uncovering pro-inflammatory responses and immune dysfunction characteristic.
Researchers at the Icahn School of Medicine at Mount Sinai have discovered how to reverse aging in blood-forming stem cells in mice by correcting defects in the stem cell's lysosomes. The breakthrough ...
In most cases, the damage is linked to mutations in the OPA1 gene, which interfere with mitochondrial function (how cells make energy and stay healthy). New research led by Thomas Schwarz, Ph.D., and ...
Senescent "zombie" cells are essential architects required to build and maintain the brain's protective barriers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results